Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
Pancreatic metastases are a rare entity. In cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection.
Goals:
- Define survival after resection of pancreatic cancer metastases renal in a wide range of our country.
- Identify predictive survival factors
Methods:
Retrospective multicenter study in which cases of pancreatic resection due to renal cancer metastases.
详细描述
Introduction:
Pancreatic metastases are a rare entity and often synonymous with broader dissemination. However, in cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection. Most of the literature refers to isolated cases or short series, with the Johns Hopkins Hospital series being the largest in a single published center (1,2). In all of them, survival after resection is prolonged.
Recently, due to the results obtained with the tyrosine kinase inhibitor drugs, the value of resection of metastases of RCC origin has been questioned in an Italian multicenter study (3), although other studies consider that resection can improve the prognosis if It is associated with these drugs (4).
Justification:
The existing literature is limited to short series or mostly isolated cases. There are no clear prognostic factors that are limited in most cases to being merely descriptive studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with resecable pancreatic metastases from RCC
排除标准
- •Unresecable pancreatic metastases
结局指标
主要结局
Overall survival
时间窗: Up to 60 months
Overall survival (months) from surgical resection of pancreatic metastases
Disease free survival
时间窗: Up to 60 months
Disease free survival (months) from surgical resection of pancreatic metastases
次要结局
未报告次要终点
研究者
Gerardo Blanco-Fernández
Head of Surgery, Clinical Professor
Universidad de Extremadura
